The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

The first study to assess how weight-loss drugs affect the whole of human health has discovered an "eye-opening" impact on ...

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a study ...

Study shows diabetes drugs' potential beyond weight loss A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including dementia and ...

The use of weight-loss jabs may be associated with wider health benefits including lower risk of stroke and dementia, a study ...

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

Researchers have found links to multiple new benefits – and new side effects – in a study of weight-loss drugs such as ...

Weight loss jabs such as Wegovy may reduce risk of dementia by easing inflammation in the brain, scientists say. The drugs ...

A study analyzing data from over 2 million veterans found that GLP-1 receptor agonists, popular weight-loss drugs like Ozempic and Wegovy, provide significant neurological and behavioral health ...

Analysis of drugs such as Ozempic finds a lower health risk for 42 conditions but a higher rate of disorders such as arthritis ...

CHARLOTTESVILLE, Va. (WVIR) - Weight loss and diabetes drugs such as Ozempic and Wegovy could possibly be covered by Medicare ...